FEBS Letters · 2002 · 37 citations · 14 references
Life SciencesMedicinal ChemistryPharmacologyCancer PharmacologyCell SignalingSignal TransductionAngiogenesisAngiogenesis In CancerGrowth Factor SignalingProtein Phosphatase SignalingReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsEndothelial Tube FormationTissue VascularizationTyrosine Kinase InhibitionVascular Endothelial Growth FactorVascular Endothelial Growth Factor InhibitionVascular Endothelial Growth Factor InhibitorsVascular Endothelial Growth Factor ReceptorsVascularization
Vascular endothelial growth factor (VEGF) and its receptors play a key role in angiogenesis. VEGF receptor-2 (VEGFR-2) has a tyrosine kinase domain, and, once activated, induces the phosphorylation of cytoplasmic signaling proteins. The phosphorylated VEGFR-2 may be a substrate for intracellular protein tyrosine phosphatases (PTPs) which prevent VEGF signaling. We synthesized a series of alpha,alpha-difluoro(phenyl)methylphosphonic acids (DFPMPAs) which inhibit the action of PTP. In this study, we test their effects on VEGF-induced angiogenesis. DFPMPA-3, the most effective inhibitor of human PTP-1B, promoted tube formation by human umbilical vein endothelial cells (HUVEC) on Matrigel more effectively than any other DFPMPAs. The inhibitor promoted the VEGF-induced proliferation and migration of HUVEC by inhibiting the dephosphorylation of VEGFR-2. Its effectiveness was proven through neo-vascularization in mice. The present findings suggest that targeting PTP to promote therapeutic neo-vascularization may be a potential strategy.
14
Vascular endothelial growth factor (VEGF) and its receptors
Gera Neufeld, Tzafra Cohen, Stela Gengrinovitch et al. · The FASEB Journal · 1999 · 3.5K citations
Medicine, Cell Biology, Oncology +17
Hans-Peter Gerber, Amy E. McMurtrey, Joe Kowalski et al. · Journal of Biological Chemistry · 1998 · 2K citations · Full text
Christoph Kalka, Haruchika Masuda, Tomono Takahashi et al. · Proceedings of the National Academy of Sciences · 2000 · 1.9K citations · Full text
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Julia A. Romashkova, Sergei S. Makarov · Nature · 1999 · 1.8K citations